Sedation for Patients Undergoing Endoscopic Retrograde Cholangiopancreatography
Propofol Sedation During Endoscopic Retrograde Cholangiopancreatography: A Comparison Between Conventional Versus Bispectral Index Guided Approach and Effect of Diclofenac Sodium Along With Topical Pharyngeal Anaesthesia
1 other identifier
interventional
90
1 country
1
Brief Summary
This study was performed to evaluate the role of BIS monitored sedation in reducing the dose of propofol and to know the effectiveness of pre-procedure administration of intravenous diclofenac sodium along with topical pharyngeal anesthesia in reducing the dose of propofol in patients undergoing endoscopic retrograde cholangiopancreatography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 14, 2019
CompletedFirst Submitted
Initial submission to the registry
April 19, 2021
CompletedFirst Posted
Study publicly available on registry
April 26, 2021
CompletedApril 26, 2021
April 1, 2021
1 year
April 19, 2021
April 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total dose of propofol required in mg/kg/hr during ERCP procedure among different groups.
Total dose of propofol required to complete the ERCP procedure was noted
2 hours
Secondary Outcomes (3)
Mean recovery time between different groups.
24 hours
Time taken to achieve eye opening to verbal stimulus among different groups
24 hours
Incidence of hypotension, bradycardia, limb movements and gag reflex during the ERCP procedure
24 hours
Study Arms (3)
Group A
NO INTERVENTIONThe intravenous infusion of propofol was administered for ERCP procedure based on clinical judgment and the patient's requirement.
Group B
ACTIVE COMPARATORThe intravenous infusion of propofol was administered for ERCP procedure titrated to BIS value 60-80.
Group C
ACTIVE COMPARATORPatients received 75 mg of inj. Diclofenac sodium (diluted in 100 ml of 0.9 % normal saline) intravenously 30 mins before the start of procedure \& topical pharyngeal anesthesia with 4 squirts of 10% lidocaine spray ( one squirt each to posterior pharyngeal wall, base of tongue, and bilateral palatoglossal and palatopharyngeal folds ) 5 mins before the start of ERCP procedure. Intravenous infusion of propofol was administered for ERCP procedure titrated to BIS value 60-80.
Interventions
Injection propofol was given to keep the BIS value 60-80 during the ERCP procedure
Injection Diclofenac sodium was given in the preoperative area 30 minutes before the procedure and four squirts of 10% lignocaine were given 5 minutes prior to the start of the procedure
Eligibility Criteria
You may qualify if:
- Age between 18-65 yrs
- ASA I \& II
You may not qualify if:
- Age \< 18 yrs \& \> 65 yrs
- ASA III \& IV patients
- Chronic Liver Disease
- Pregnant patients
- Patients with a history of (H/O) Drug abuse
- Patients refusing consent
- H/o Acute kidney injury
- H/o allergy to propofol / lidocaine/ NSAIDS
- Post liver transplant patients
- Patients with h/o egg allergy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaurav Sindwani
New Delhi, National Capital Territory of Delhi, 110060, India
Related Publications (5)
Patai A, Solymosi N, Mohacsi L, Patai AV. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials. Gastrointest Endosc. 2017 Jun;85(6):1144-1156.e1. doi: 10.1016/j.gie.2017.01.033. Epub 2017 Feb 4.
PMID: 28167118RESULTQuesada N, Judez D, Martinez Ubieto J, Pascual A, Chacon E, De Pablo F, Minchole E, Bello S. Bispectral Index Monitoring Reduces the Dosage of Propofol and Adverse Events in Sedation for Endobronchial Ultrasound. Respiration. 2016;92(3):166-75. doi: 10.1159/000448433. Epub 2016 Sep 7.
PMID: 27598398RESULTWehrmann T, Grotkamp J, Stergiou N, Riphaus A, Kluge A, Lembcke B, Schultz A. Electroencephalogram monitoring facilitates sedation with propofol for routine ERCP: a randomized, controlled trial. Gastrointest Endosc. 2002 Dec;56(6):817-24. doi: 10.1067/mge.2002.129603.
PMID: 12447291RESULTWhite PF, Sacan O, Tufanogullari B, Eng M, Nuangchamnong N, Ogunnaike B. Effect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery. Can J Anaesth. 2007 May;54(5):342-8. doi: 10.1007/BF03022655.
PMID: 17470884RESULTPaspatis GA, Chainaki I, Manolaraki MM, Vardas E, Theodoropoulou A, Tribonias G, Konstantinidis K, Karmiris K, Chlouverakis G. Efficacy of bispectral index monitoring as an adjunct to propofol deep sedation for ERCP: a randomized controlled trial. Endoscopy. 2009 Dec;41(12):1046-51. doi: 10.1055/s-0029-1215342. Epub 2009 Dec 4.
PMID: 19967620RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
gaurav sindwani, md
ilbs
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor, Department of Anaesthesiology, Principal Investigator
Study Record Dates
First Submitted
April 19, 2021
First Posted
April 26, 2021
Study Start
September 10, 2018
Primary Completion
September 26, 2019
Study Completion
November 14, 2019
Last Updated
April 26, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share